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Abstract 
 
   Propranolol is a representative β-blocker used for the treatment of cardiovascular diseases.  Because the use 
of propranolol expands for some clinical purposes that are not related to its β-blocking action, it is necessary to 
further examine cellular actions of propranolol.  We revealed that propranolol decreased the intracellular Zn2+ 
level in rat thymocytes by the use of cytometric technique with FluoZin-3, a fluorescent indicator of intracellular 
Zn2+.  Propranolol decreased the influx of extracellular Zn2+.  However, the agent decreased the intracellular 
Zn2+ level even in the presence of DTPA, a chelator of extracellular Zn2+.  Thus, the decrease in intracellular 
Zn2+ level by propranolol was not due to the decrease in Zn2+ influx by propranolol.  Propranolol increased the 
cellular content of nonprotein thiol that was estimated by the use of 5-chloromethylfluorescein fluorescence, an 
indicator for non-proteinous thiol.  Since non-proteinous thiols can make a complex with Zn2+, propranolol may 
increase the cellular content of nonprotein thiol, resulting in the decrease in intracellular Zn2+ level.  Since the 
concentrations of propranolol to affect both intracellular Zn2+ level and cellular content of nonprotein thiol are 
higher than those reported under clinical conditions, it is difficult to emphasize clinical implications from present 
results. 
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1. Introduction 
 
   Propranolol, a representative β-blocker, is used 
for the treatment of hypertension and arrhythmia 
(Nies and Shand, 1975).  This agent possesses a 
potent local-anesthetic activity that confers 
membrane-stabilizing action (Morales-Aguilerá and 
Vaughan Williams, 1965).  The membrane 
stabilizing action of propranolol is usually explained 
by the phenomenon that propranolol suppresses a 
voltage-dependent Na+ channel, resulting in the 
attenuation of membrane excitability.  In our 
previous studies, tetracaine decreased the intracellular 
Zn2+ level (Kimura et al., 2011) whereas lidocaine 
increased it (Nishimura and Oyama, 2009, 2012).  
Although both agents are local anesthetics, they 
exerted opposite actions.  Therefore, we examined 
the effect of propranolol on intracellular Zn2+ level in 
rat thymocytes by the use of FluoZin-3 fluorescence 
because of a following reason.  Propranolol is 
relatively safe in clinical use.  The use of 
propranolol expands for some clinical purposes that 
are not related to its β receptor blocking action.  
Therefore, it is necessary to further examine cellular 
actions (or cytotoxic actions) of propranolol. 
 
 
2. Materials and methods 
 
2.1. Chemicals 
   Propranolol hydrochloride (d,l-types) was 
purchased from Sigma-Aldrich Corp. (St. Louis, MO, 
USA).  Tetracaine hydrochloride, NaCl, CaCl2, 
MgCl2, KCl, glucose, HEPES, NaOH, and dimethyl 
sulfoxide (DMSO) were obtained from Wako Pure 
Chemicals (Osaka, Japan).  FluoZin-3-AM and 
propidium iodide were obtained from Molecular 
Probes Inc. - Invitrogen (Eugene, Oregon, USA).  
FluoZin-3-AM was initially dissolved in DMSO.  
The final concentration of DMSO in the cell 
suspension (maximum 0.2 %) did not affect any 
fluorescence. Diethylenetriamine-pentaacetic acid 
(DTPA), a Zn2+ chelator, was obtained from Dojin 
Chemical Laboratory (Kumamoto, Japan). 
 
2.2. Animals and cell preparation 
   This study was approved by the Committee for 
Animal Experiments at the University of Tokushima 
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(No. 05279).  The cell suspension was prepared in a 
similar manner to that reported previously (Chikahisa 
et al., 1996; Matsui et al., 2008; Kinazaki et al., 2011).  
In brief, thymus glands dissected from 
ether-anesthetized rats were sliced at a thickness of 
1–2 mm with a blade under cold conditions (3–4°C).  
The slices were triturated by gently shaking in 
Tyrode's solution (in mM: NaCl 150, KCl 5, CaCl2 2, 
MgCl2 1, glucose 5, HEPES 5; pH adjusted to 7.3–7.4 
with NaOH) to dissociate the thymocytes.  
Thereafter, the Tyrode's solution containing the cells 
was passed through a mesh (diameter 10 µm) to 
prepare the cell suspension.  The beaker containing 
the cell suspension was incubated in a water bath at 
36–37°C for 1 h before the experiment.  Although 
the Tyrode's solution did not contain ZnCl2, the cell 
suspension generally contained 200–230 nM zinc 
derived from the cell preparation (Sakanashi et al., 
2009). 
   Rat thymocytes were used for the study because 
single cells can be prepared without enzymatic 
treatment; thus, their cell membranes remain intact.  
In addition, the modification of cell death (apoptosis 
and necrosis) by zinc has been studied extensively in 
murine thymocytes (Barbieri et al., 1992; McCabe et 
al., 1993; Provinciali et al., 1995; Maclean et al., 
2001). 
 
2.3. Fluorescence measurements of cellular and 
membrane parameters 
   The methods for measuring the cellular and 
membrane parameters by using a flow cytometer 
equipped with an argon laser (CytoACE-150; JASCO, 
Tokyo, Japan) and fluorescent probes were similar to 
those described previously (Chikahisa et al., 1996; 
Matsui et al., 2008).  The fluorescence was analyzed 
by JASCO software (Version 3.06; JASCO). 
   To assess cell lethality, propidium iodide was 
added to the cell suspensions to a final concentration 
of 5 µM.  Because propidium stains dead cells, the 
measurement of propidium fluorescence from the 
cells provided information on lethality.  The 
fluorescence was measured 2 min after the 
application of propidium iodide by a flow cytometer.  
The excitation wavelength used for propidium was 
488 nm and the emission was detected at 600 ± 20 
nm. 
   FluoZin-3-AM (Gee et al., 2002) was used as an 
indicator of intracellular Zn2+.  The cells were 
incubated with 500 nM FluoZin-3-AM for 60 min 
before any fluorescence measurements were taken to 
estimate the change in the intracellular Zn2+ level of 
the rat thymocytes with intact membranes.  
FluoZin-3 fluorescence was measured in the cells that 
were not stained with propidium iodide (Matsui et al., 
2008).  The excitation wavelength used for 
FluoZin-3 was 488 nm and the emission was detected 
at 530 ± 20 nm. 
   5-CMF-DA was used to monitor changes in the 
cellular content of nonprotein thiols (Chikahisa et al., 
1996).  The cells were incubated with 1 µM 
5-CMF-DA for 30 min before any fluorescence 
measurements were taken.  5-CMF fluorescence was 
measured in the cells that were not stained with 
propidium iodide.  The excitation wavelength used 
for 5-CMF was 488 nm, and the emission was 
detected at 530 ± 15 nm. 
   The agents were added to the cell suspension (2 
mL) and the cells were incubated at 36–37°C under 
room air conditions.  The incubation time was 
dependent on each experiment.  The acquisition of 
the fluorescence data from 2000 or 2500 cells using a 
flow cytometer required the time of 30 s or less and 
100 µL of the cell suspension was used for the 
fluorescence measurements. 
 
2.4. Statistics 
   Values were expressed as the mean ± standard 
deviation of 4 experiments.  Statistical analysis was 
performed with Tukey's multivariate analysis.  A P 
value of < 0.05 was considered significant. 
 
 
 
Figure 1. Concentration-dependent change in the intensity 
of FluoZin-3 fluorescence as a result of propranolol 
application.  Effects were examined 60 min after the start 
of drug application.  The columns and bars indicate the 
mean and standard deviation, respectively, of 4 
experiments.  Dotted line indicates control level.  
Symbols (*,**) indicate a significant difference (P < 0.05, 
0.01) between the control group (CONTROL) and the 
groups of cells treated with propranolol.  The experiments 
were performed in duplicate and reproduced twice.  One 
representative experiment is shown. 
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3. Results 
 
3.1. Effect of propranolol on the FluoZin-3 
fluorescence of rat thymocytes 
   The treatment of cells with 100 µM propranolol 
for 1 hr slightly shifted the histogram of FluoZin-3 
fluorescence to a direction of lower intensity, 
suggesting the decrease in intracellular Zn2+ level by 
propranolol.  The threshold concentration of 
propranolol to attenuate the FluoZin-3 fluorescence 
was 10 µM (Fig. 1).  Further increases in 
propranolol concentration (30–100 µM) induced 
further attenuation of FluoZin-3 fluorescence (Fig. 
1B).  The attenuation of FluoZin-3 fluorescence by 
propranolol (30–100 µM) was statistically significant. 
 
3.2. Effect of DTPA on the propranolol-induced 
change in FluoZin-3 fluorescence 
   To remove the contribution of extracellular Zn2+, 
the effect of propranolol was examined in the 
presence of 10 µM DTPA.  As shown in Fig. 2, the 
incubation of cells with DTPA for 1 hr attenuated the 
FluoZin-3 fluorescence, suggesting the decrease in 
intracellular Zn2+ level by removing extracellular Zn2+.  
In the presence of DTPA, 30 µM propranolol still 
induced significant attenuation of FluoZin-3 
fluorescence (Fig. 2).  
 
 
 
Figure 2. Effect of propranolol on FluoZin-3 fluorescence 
in the presence of DTPA.  The columns and bars indicate 
the mean intensity and standard deviation, respectively, of 
4 experiments.  The symbol (**) indicates significant 
differences (P < 0.01) between the control group and the 
group of cells treated with propranolol. 
 
 
3.3. Effect of propranolol on the Zn2+ influx induced 
by the external addition of ZnCl2 
   The results shown in Fig. 2 suggested that 
extracellular Zn2+ was not involved in the 
propranolol-induced attenuation of FluoZin-3 
fluorescence.  However, it was presumably 
suggested that the Zn2+ influx maintained intracellular 
Zn2+ level because DTPA attenuated the FluoZin-3 
fluorescence.  To test whether propranolol affects 
Zn2+ influx, the effect of propranolol on the 
augmentation of FluoZin-3 fluorescence induced by 
external addition of ZnCl2 was examined.  The 
augmentation of FluoZin-3 fluorescence by adding 
ZnCl2 (presumably Zn2+ influx) was diminished under 
cold condition (1–4°C) (Kimura et al., 2011).  The 
addition of 10 µM ZnCl2 into the cell suspension 
significantly augmented the FluoZin-3 fluorescence.  
The treatment of cells with 1–3 µM propranolol for 1 
hr did not affect the augmentation of FluoZin-3 
fluorescence.  Increases in propranolol concentration 
(up to 100 µM) attenuated the increase in the 
intensity of FluoZin-3 fluorescence by the addition of 
ZnCl2 (Fig. 3).  The augmentation of FluoZin-3 
fluorescence by ZnCl2 was significantly reduced by 
30–100 µM propranolol.  The reduction by 10 µM 
propranolol was not statistically significant. 
 
 
 
Figure 3. Effect of propranolol on the FluoZin-3 
fluorescence augmented by the external application of 
ZnCl2.  The columns and bars indicate the mean intensity 
and standard deviation, respectively, of 4 experiments.  
Dotted line shows control level after the application of 
ZnCl2.  The symbols (*,**) indicate significant differences 
(P < 0.05, 0.01) between the control group and the groups 
of cells treated with propranolol. 
 
 
3.4. Effect of propranolol on cellular content of 
nonprotein thiol 
   Cellular content of nonprotein thiol is mutually 
associated with intracellular Zn2+ concentration 
(Kinazaki et al., 2011).  Propranolol may change 
cellular content of nonprotein thiol.  In this study, 
we examined the change in 5-CMF fluorescence, a 
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parameter of nonprotein thiol, in the cells treated with 
propranolol.  The cells were treated with 10–300 
µM propranolol for 60 min and then 5-CMF-DA was 
applied to the cells.  Thereafter, 5-CMF fluorescence 
was measured at 40 min after the application of 
5-CMF-DA (Chikahisa et al., 1996).  As shown in 
Fig. 4, the incubation of cells with propranolol at 
concentrations ranging from 10 µM to 300 µM 
induced concentration-dependent augmentation of 
5-CMF fluorescence.  The augmentation only by 
300 µM propranolol was statistically significant.  
The result suggested that propranolol at 300 µM 
significantly increased cellular content of nonprotein 
thiol (not shown in Fig. 4).  Control intensity was 
52.0 ±  4.1 (arbitrary unit, mean ± SD of four 
experiments) while it was 75.3 ± 8.2 after the 
incubation with 300 µM propranolol for 60 min. 
 
 
 
Figure 4.  Effect of propranolol on 5-CMF fluorescence.  
Dotted line indicates control level.  The columns and bars 
indicate the mean intensity and standard deviation, 
respectively, of 4 experiments. 
 
 
 
 
Figure 5.  Comparison of propranolol with tetracaine. 
The columns and bars indicate the mean intensity and 
standard deviation, respectively, of 4 experiments.  
Dotted line shows control level.  The symbol (**) 
indicates significant differences (P < 0.01) between the 
control group and the group of cells treated with the drug. 
3.5. Comparison with tetracaine 
   Propranolol possesses a local anesthetic activity 
(Morales-Aguilerá and Vaughan Williams, 1965).  
Since tetracaine attenuated the increase in 
intracellular Zn2+ concentration induced by the 
application of ZnCl2 (Kimura et al., 2011), the effect 
of propranolol was compared with that of tetracaine.  
Their effects at the concentration of 100 µM were 
examined.  Propranolol and tetracaine decreased the 
intensity of FluoZin-3 fluorescence (Fig. 5).  The 
potency of propranolol was greater than that of 
tetracaine.  Therefore, the agents were supposed to 
attenuate the increase in the intensity of FluoZin-3 
fluorescence by the addition of ZnCl2 into the 
suspension. 
 
 
4. Discussion 
 
   The relation between FluoZin-3 fluorescence and 
5-CMF fluorescence showed a negative correlation in 
the cells under some chemical stresses induced by 
N-ethylmaleimide (Hashimoto et al., 2009; Kawanai 
et al., 2009; Oyama et al., 2009; Kinazaki et al., 
2011).  Decrease in cellular content of nonprotein 
thiol seemed to induce intracellular Zn2+ release.  
Such a negative relationship between them is true 
because intracellular Zn2+ makes a complex with the 
thiol group of protein and nonprotein (Jacob et al., 
1998), and the modification from thiol to disulfide 
releases Zn2+ from protein and nonprotein (Maret et 
al., 1994).  Propranolol slightly augmented the 
5-CMF fluorescence, indicating the increase in 
cellular content of nonprotein thiol.  This 
phenomenon may decrease intracellular Zn2+ release, 
resulting in the decrease in intracellular Zn2+ 
concentration. 
   Propranolol possesses local anesthetic action 
(Morales-Aguilerá and Vaughan Williams, 1965).  
However, this action is approximately two order of 
magnitude higher in concentration than that necessary 
for expression of the β-adrenergic antagonism.  The 
local anesthetic activity of propranolol may be related 
to its action on intracellular Zn2+ level because 
micromolar concentrations (> 10 µM) were required 
to affect intracellular Zn2+ level (Figs. 1 and 2).  
However, tetracaine attenuated the FluoZin-3 
fluorescence whereas lidocaine augmented it (Kimura 
et al., 2011; Nishimura and Oyama, 2012).  
Therefore, local anesthetics seem to be further 
classified by their actions on intracellular Zn2+ level. 
   The blood concentration of propranolol in human 
after a single oral dose (80 mg) was less than 1 µM 
(Mahajan et al., 1984).  The concentrations of 
propranolol to exert the action on intracellular Zn2+ 
level were micromolar in this study (Figs. 1 and 2).  
The micromolar concentration of propranolol was 
observed in the blood of fatal case (Hong et al., 1983).  
Therefore, it is quite difficult to emphasize clinical 
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implications on the action of propranolol on 
intracellular Zn2+ level. 
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